Moderna Burns Cash, Suffers Fresh Vaccine Setback

Moderna Inc. (NASDAQ:MRNA) on Friday reported a second-quarter loss of $1.97 per share, beating the consensus loss of $2.10 per share. The COVID-19 vaccine maker reported sales of $145 million, better than the Wall Street estimate of $102.998 million. Lower COVID...

Telus Stock Slides After Disappointing Q2 Results

Telus Corp. (NYSE:TU) shares are tumbling Friday after the Canadian telecommunications giant delivered a second-quarter report that fell short on every major metric and unveiled a dividend reduction of more than half. Here’s what you should know. TELUS shares are...